Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy

Kidney International

Volumn 74, Issue 7, 2008, Pages 901-909

  Klein, Christina L ^a   Hoke, Tom S ^a   Fang, Wen Feng ^b   Altmann, Christopher J ^a   Douglas, Ivor S ^a   Faubel, Sarah ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Acute renal failure; CXCL1; CXCL2; Interleukin 6; KC; MIP 2

Indexed keywords

CHEMOKINE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY ISCHEMIA; LUNG CAPILLARY; LUNG INJURY; MALE; MOUSE; NEPHRECTOMY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WILD TYPE;

ANIMALS; CAPILLARY PERMEABILITY; CHEMOKINES; INTERLEUKIN-6; ISCHEMIA; KIDNEY FAILURE, ACUTE; LUNG DISEASES; MICE; MICE, KNOCKOUT; NEPHRECTOMY; NEUTROPHIL INFILTRATION; PEROXIDASE;

EID: 51849138935     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.314     Document Type: Article

References (49)

1. Chertow GM, Christiansen CL, Cleary PD et al. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Int Med 1995; 155: 1505-1511.
2. Waikar SS, Liu KD, Chertow GM. The incidence and prognostic significance of acute kidney injury. Curr Opin Nephrol Hypertens 2007; 16: 227-236.
3. Vieira Jr JM, Castro I, Curvello-Neto A et al. Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients. Crit Care Med 2007; 35: 184-191.
4. Marenzi G, Assanelli E, Marana I et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006; 354: 2773-2782.
5. Hoke TS, Douglas IS, Klein CL et al. Acute renal failure following bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 2006; 18: 155-164.
6. Kramer AA, Postler G, Salhab KF et al. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 1999; 55: 2362-2367.
7. Hassoun HT, Grigoryev DN, Lie ML et al. Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol 2007; 293: F28-F29.
8. Deng J, Hu X, Yuen PS et al. Alpha-melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion. Am J Resp Crit Care Med 2004; 169: 749-756.
9. Nath KA, Grande JP, Croatt AJ et al. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol 2005; 166: 963-972.
10. Kim DJ, Park SH, Sheen MR et al. Comparison of experimental lung injury from acute renal failure with injury due to sepsis. Respiration 2006; 73: 815-824.
11. Rabb H, Wang Z, Nemoto T et al. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int 2003; 63: 600-606.
12. Star RA. Treatment of acute renal failure. Kidney Int 1998; 54: 1817-1831.
13. Welbourn R, Goldman G, O'Riordain M et al. Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol 1991; 70: 2645-2649.
14. Colletti LM, Cortis A, Lukacs N et al. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998; 10: 182-191.
15. Colletti LM, Kunkel SL, Walz A et al. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J Clin Investig 1995; 95: 134-141.
16. Seekamp A, Mulligan MS, Till GO et al. Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs. Am J Pathol 1993; 143: 464-472.
17. Yoshidome H, Lentsch AB, Cheadle WG et al. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. J Surg Res 1999; 81: 33-37.
18. Heidland A, Heine H, Heidbreder E et al. Uremic pneumonitis. Evidence for participation of proteolytic enzymes. Contrib Nephrol 1984; 41: 352-366.
19. Simmons EM, Himmelfarb J, Sezer MT et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004; 65: 1357-1365.
20. Meduri GU, Kohler G, Headley S et al. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995; 108: 1303-1314.
21. Parsons PE, Eisner MD, Thompson BT et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33: 1-6.
22. Rijneveld AW, van den Dobbelsteen GP, Florquin S et al. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J Infect Dis 2002; 185: 123-126.
23. McClintock SD, Barron AG, Olle EW et al. Role of interleukin-6 in a glucan-induced model of granulomatous vasculitis. Exp Mol Pathol 2007; 82: 203-209.
24. Johnston RA, Schwartzman IN, Flynt L et al. Role of interleukin-6 in murine airway responses to ozone. Am J Physiol Lung Cell Mol Physiol 2005; 288: L390-L397.
25. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005; 77: 598-625.
26. Johnson KJ, Fantone JC, Kaplan J et al. In vivo damage of rat lungs by oxygen metabolites. J Clin Invest 1981; 67: 983-993.
27. Bates DW, Su L, Yu DT et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis 2001; 32: 686-693.
28. Chertow GM, Levy EM, Hammermeister KE et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998; 104: 343-348.
29. Lassnigg A, Schmidlin D, Mouhieddine M et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004; 15: 1597-1605.
30. Parikh CMPKD, Ecder T, Taylor J et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 2002; 62: 566-573.
31. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-1494.
32. Bleyl U, Sander E, Schindler T. The pathology and biology of uremic pneumonitis. Intensive Care Med 1981; 7: 193-202.
33. Hopps HC, Wissler RW. Uremic pneumonitis. Am J Pathol 1955; 31: 261-273.
34. Zettergren L. Uremic lung; report of four cases reaching autopsy. Acta Soc Med Ups 1955; 30: 161-171.
35. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 1549-1558.
36. Meduri GU, Headley S, Kohler G et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107: 1062-1073.
37. Romano M, Sironi M, Toniatti C et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315-325.
38. Hurst SM, Wilkinson TS, McLoughlin RM et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14: 705-714.
39. Molls RR, Savransky V, Liu M et al. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol 2006; 290: F1187-F1193.
40. Modur V, Li Y, Zimmerman GA et al. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Investig 1997; 100: 2752-2756.
41. Grigoryev DN, Liu M, Hassoun HT et al. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 2008; 19: 547-558.
42. Nechemia-Arbely Y, Barkan D, Pizov G et al. IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol 2008; 6: 1106-1115.
43. Frieling JT, van Hamersvelt HW, Wijdenes J et al. Circulating concentrations of soluble interleukin 6 receptors gp80 and gp130 in chronic renal failure and effects of renal replacement therapy. Am J Nephrol 1999; 19: 571-575.
44. Kielar ML, John R, Bennet M et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 2006; 16: 3315-3325.
45. Castell JV, Geiger T, Gross V et al. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem 1988; 177: 357-361.
46. Melnikov VY, Faubel SG, Siegmund B et al. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 2002; 110: 1083-1091.
47. Faubel SG, Ljubanovic D, Poole B et al. Peripheral CD4 T cell depletion is not sufficient to prevent ischemic acute renal failure. Transplantation 2005; 80: 643-649.
48. Kasahara Y, Tuder RM, Taraseviciene-Stewart L et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106: 1211-1219.
49. Melnikov VY, Ecder T, Fantuzzi G et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 2001; 107: 1145-1152.